GELATIN POLYSUCCINATE
About GELATIN POLYSUCCINATE
GELATIN POLYSUCCINATE is a sterile solution indicated for the prophylaxis and treatment of absolute and relative hypovolemia, shock, and hypotension. It is also indicated in acute normovolemic hemodilution and extracorporeal circulation.
GELATIN POLYSUCCINATE contains Gelatin polysuccinate, which is a colloidal volume replacement solution that provides an efficient and reliable volume effect. It provides appropriate and reliable hemodynamic stabilisation.
GELATIN POLYSUCCINATE will be administered by a healthcare professional; do not self-administer. In some cases, GELATIN POLYSUCCINATE may cause fever, urticarial/hives, or sudden flushing of the neck and face. Talk to the doctor if you notice any side effects while on treatment with GELATIN POLYSUCCINATE.
Let the doctor know if you are allergic to any components in GELATIN POLYSUCCINATE. Consult the doctor if you are pregnant or breastfeeding. Keep your doctor informed about your health condition and medications to rule out any side effects/interactions.
Uses of GELATIN POLYSUCCINATE
Medicinal Benefits
GELATIN POLYSUCCINATE is a sterile solution indicated for the prophylaxis and treatment of absolute and relative hypovolemia, shock, and hypotension. It is also indicated in acute normovolemic hemodilution and extracorporeal circulation. GELATIN POLYSUCCINATE contains Gelatin polysuccinate, which is a colloidal volume replacement solution that provides an efficient and reliable volume effect. It provides appropriate and reliable hemodynamic stabilisation.
Directions for Use
Storage
Side Effects of GELATIN POLYSUCCINATE
- Fever
- Urticaria/hives
- Sudden flushing of the face and neck
Drug Warnings
Do not use GELATIN POLYSUCCINATE if you are allergic to any of its components or if you have hypervolemia, hyperhydration, severe cardiac insufficiency, recent cardiac infraction, severe renal insufficiency or severe disturbances of blood coagulation. Inform the doctor if you have asthma, dehydration, bleeding tendency, hypernatraemia (high sodium level), left or right ventricular insufficiency, blood coagulation disorders, chronic liver disease, or renal insufficiency. Consult the doctor if you are pregnant or breastfeeding. Let your doctor know if you are taking any prescription/non-prescription medicines or herbal supplements.
Drug Interactions
Drug-Drug Interactions: No interactions found/established.
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: No interactions found/established.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorIt is unknown if alcohol interacts with GELATIN POLYSUCCINATE. Please consult the doctor.
Pregnancy
cautionGelatin polysuccinate belongs to pregnancy category C. It should be used during pregnancy only if the benefits outweigh the risks.
Breast Feeding
cautionIt is not known if Gelatin polysuccinate passes into breast milk. Consult the doctor if you are breastfeeding.
Driving
consult your doctorIt is not known if GELATIN POLYSUCCINATE affects your ability to drive. Drive and operate machinery only if you are alert.
Liver
cautionIf you have a history of liver impairment, inform the doctor before receiving GELATIN POLYSUCCINATE. Special caution and careful dose adjustment may be needed in patients with chronic liver disease.
Kidney
cautionIf you have a history of kidney impairment, inform the doctor before receiving GELATIN POLYSUCCINATE. Special caution and careful dose adjustment may be needed in patients with renal insufficiency. It may not be recommended in patients with severe renal insufficiency.
Children
cautionSufficient experience in children below 1 year is not available. Please consult the doctor if you have any concerns regarding the usage of GELATIN POLYSUCCINATE in children.
Habit Forming
Diet & Lifestyle Advise
- Drink a lot of water and other fluids.
- Eat a proper diet and maintain healthy body weight.
- Manage stress with meditation or yoga.
- Avoid smoking and alcohol consumption.
- Rest well; get optimum sleep.
Special Advise
GELATIN POLYSUCCINATE may affect certain lab tests such as unspecific plasma protein assays, erythrocyte sedimentation rate or specific gravity of urine. If you are undergoing any tests, inform the doctor that you are on treatment with GELATIN POLYSUCCINATE.
Patients Concern
Disease/Condition Glossary
Hypovolemia: Hypovolemia, also called volume depletion, is a condition in which the plasma (liquid portion of the blood) is too low. Excessive bleeding, vomiting, or diarrhoea could be the causes of hypovolemia. Symptoms include fatigue, weakness, dizziness, and fainting.
Shock: Shock occurs when the body is not getting enough blood flow, due to which the cells and organs do not get enough oxygen and nutrients to function properly. This may result in organ damage. It is a life-threatening condition which requires immediate treatment.
Hypotension: Hypotension, also known as low blood pressure, is a condition in which the blood pressure is much lower than normal. This may cause dizziness or fainting because the brain does not receive enough blood.
Acute normovolemic hemodilution: It is a blood conservation technique in which the whole blood from the patient’s body is removed after induction of anaesthesia, with maintenance of normal blood volume using colloid replacement fluid and/or crystalloid.
Extracorporeal circulation: It is a procedure in which blood is taken from a patient’s circulation to have a process applied to it before it is returned to circulation.
FAQs
GELATIN POLYSUCCINATE is used to treat Hypovolemia, shock, hypotension, acute normovolemic hemodilution and extracorporeal circulation.
GELATIN POLYSUCCINATE provides an efficient and reliable volume effect. It provides appropriate and reliable hemodynamic stabilisation.
GELATIN POLYSUCCINATE may not be recommended for patients with severe cardiac insufficiency. Inform the doctor if you have severe cardiac insufficiency before receiving GELATIN POLYSUCCINATE.
Inform the doctor if you have blood coagulation disorders, as special caution and careful dose adjustment may be needed in such patients.
